Last reviewed · How we verify

NCT07428317: OBY-GEL

Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery

Recruiting now NA Last updated 23 February 2026
What this trial tests

NA trial testing Obstetric Lubricant Gel in Prolonged Second Stage of Labor in 160 participants. Currently enrolling.

Timeline
16 February 2026
Primary endpoint
31 August 2026
30 September 2026

Quick facts

Lead sponsorUniversidad Nacional Autonoma de Honduras
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment160
Start date16 February 2026
Primary completion31 August 2026
Estimated completion30 September 2026
Sites1 location across Honduras

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Nacional Autonoma de Honduras — full company profile →

Who can join

Adults 18 to 49, female only, with Prolonged Second Stage of Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This experimental study aims to evaluate whether the application of obstetric lubricant gel during vaginal delivery can significantly reduce the duration of the second stage of labor, preserve perineal integrity, and decrease the need for episiotomies. The study hypothesis is that lubricant gel facilitates fetal passage through the birth canal by reducing friction, shortening the expulsion phase and reducing maternal-neonatal complications. Two groups will be included: with and without gel application. Follow-up will span from admission of the pregnant woman until immediate postpartum discharge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universidad Nacional Autonoma de Honduras trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07428317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing